Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.36 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6448096 | 1.00 | ALDH1A1 (0.40) | ALDH1A1MAPTSMN1; SMN2FAAHKMT2A | |
| SCHEMBL6448295 | 0.84 | L3MBTL1 (0.40) | ALDH1A1MAPTSMN1; SMN2KMT2AL3MBTL1 | |
| SCHEMBL6448288 | 0.84 | L3MBTL1 (0.40) | ALDH1A1MAPTSMN1; SMN2KMT2AL3MBTL1 | |
| SCHEMBL6446835 | 0.83 | HCRTR2 (0.39) | ALDH1A1MAPTSMN1; SMN2KMT2ACXCL8 | |
| SCHEMBL6450358 | 0.83 | PDK2 (0.40) | ALDH1A1MAPTSMN1; SMN2KMT2AL3MBTL1 | |
| SCHEMBL6446836 | 0.83 | HCRTR2 (0.39) | ALDH1A1MAPTSMN1; SMN2KMT2ACXCL8 | |
| SCHEMBL6450356 | 0.83 | PDK2 (0.40) | ALDH1A1MAPTSMN1; SMN2KMT2AL3MBTL1 | |
| SCHEMBL6450146 | 0.79 | KMT2A (0.38) | ALDH1A1MAPTSMN1; SMN2FAAHKMT2A | |
| SCHEMBL6450150 | 0.79 | KMT2A (0.38) | ALDH1A1MAPTSMN1; SMN2FAAHKMT2A | |
| SCHEMBL6450387 | 0.79 | L3MBTL1 (0.42) | ALDH1A1MAPTSMN1; SMN2FAAHL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6921832-B2 | Optically active fluorine-containing compounds and processes for their production | TOSOH CORPORATION (JP) | 2005-07-26 | — | — | US | disclosed |
| US-20040147756-A1 | Optically active fluorine-containing compounds and processes for their production | TOSOH CORPORATION (JP) | 2004-07-29 | — | — | US | disclosed |
| EP-1422226-A1 | Optically active fluorine-containing compounds and processes for their production | Tosoh Corporation (JP) | 2004-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147756-A1 | Optically active fluorine-containing compounds and processes for their production | CYP2C19, CYP2F1, CYP2B6 | ALDH1A1 898/4885MAPT 3196/4885SMN1; SMN2 3381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.